Cabaletta Bio Inc (CABA)
1.87
-0.39
(-17.26%)
USD |
NASDAQ |
Nov 21, 16:00
1.94
+0.07
(+3.74%)
After-Hours: 06:46
Cabaletta Bio Total Liabilities (Quarterly): 30.17M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 30.17M |
| June 30, 2024 | 17.90M |
| March 31, 2024 | 18.74M |
| December 31, 2023 | 17.45M |
| September 30, 2023 | 12.36M |
| June 30, 2023 | 10.50M |
| March 31, 2023 | 11.80M |
| December 31, 2022 | 12.45M |
| September 30, 2022 | 5.801M |
| June 30, 2022 | 6.486M |
| March 31, 2022 | 6.935M |
| December 31, 2021 | 8.38M |
| Date | Value |
|---|---|
| September 30, 2021 | 6.023M |
| June 30, 2021 | 5.601M |
| March 31, 2021 | 3.969M |
| December 31, 2020 | 5.18M |
| September 30, 2020 | 4.265M |
| June 30, 2020 | 3.263M |
| March 31, 2020 | 3.256M |
| December 31, 2019 | 3.147M |
| September 30, 2019 | 101.02M |
| June 30, 2019 | 1.876M |
| December 31, 2018 | 44.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.147M
Minimum
Dec 2019
30.17M
Maximum
Sep 2024
9.683M
Average
6.710M
Median
Total Liabilities (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 76.47B |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 204.41M |
| Shareholders Equity (Quarterly) | 174.24M |